Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Uk Mhra Gmp
  6. /
  7. SEQIRUS VACCINES LIMITED
Uk Mhra Gmp
•SEQIRUS VACCINES LIMITED•January 8, 2025

SEQIRUS VACCINES LIMITED – UK MHRA GMP Certificate UK MIA 18532 Insp GMP/IMP 18532/29956-0052[H]

Record Details

This Uk Mhra Gmp record concerns SEQIRUS VACCINES LIMITED, with an inspection on January 8, 2025, issued by the MHRA, covering biologics.

Company
SEQIRUS VACCINES LIMITED
Compliance status
GMPC
Certificate type
GMP/IMP
Inspection date
January 8, 2025
Issued
February 4, 2025
MIA number
UK MIA 18532
Site address
GASKILL ROAD, SPEKE, LIVERPOOL, L24 9GR, UNITED KINGDOM
Country
UNITED KINGDOM
Products
Human Medicinal Products
Manufacturing operations
1. MANUFACTURING OPERATIONS [ 1.1 ] Sterile Products [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) [ 1.1.1.6 ] Other aseptically prepared productsVaccines [ 1.3 ] Biological medicinal products [ 1.3.1 ] Biological medicinal products [ 1.3.1.2 ] Immunological products [ 1.3.1.8 ] Other biological medicinal productsVaccines [ 1.3.2 ] Batch certification [ 1.3.2.2 ] Immunological products [ 1.3.2.8 ] Other biological medicinal productsVaccines [ 1.4 ] Other products or manufacturing activity [ 1.4.2 ] Sterilisation of active substances/excipients/finished products: [ 1.4.2.1 ] Filtration [ 1.5 ] Packaging [ 1.5.1 ] Primary packaging [ 1.5.1.17 ] Other non-sterile medicinal productsVaccines [ 1.5.2 ] Secondary packaging [ 1.6 ] Quality control testing [ 1.6.1 ] Microbiological: sterility [ 1.6.2 ] Microbiological: non-sterility [ 1.6.3 ] Chemical/Physical [ 1.6.4 ] Biological 2. IMPORTATION OF MEDICINAL PRODUCTS [ 2.1 ] Quality control testing of imported medicinal products [ 2.1.1 ] Microbiological: sterility [ 2.1.2 ] Microbiological: non-sterility [ 2.1.3 ] Chemical/Physical [ 2.1.4 ] Biological [ 2.2 ] Batch certification of imported medicinal products [ 2.2.1 ] Sterile Products [ 2.2.1.1 ] Aseptically prepared [ 2.2.1.2 ] Terminally sterilised [ 2.2.3 ] Biological medicinal products [ 2.2.3.2 ] Immunological products [ 2.2.3.8 ] Other biological medicinal productsVaccines [ 2.3 ] Other Importation Activities [ 2.3.1 ] Site of Physical Importation [ 2.3.4 ] OtherImportation, testing and release of Neuraminidase inhibitor
Restrictions
This certificate is issued based on a desk-based assessment of GMP compliance information provided by the manufacturer. This certificate should be us ed in combination with the relevant authorisation/registration. A risk-based site inspection programme remains in force.
View Company Profile

ID · e86a83c9-0d67-4823-aeb6-af5101d9fb01

Other documents for SEQIRUS VACCINES LIMITED
  • 483 - 2023-05-26May 26, 2023

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore SEQIRUS VACCINES LIMITED
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.